These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
692 related articles for article (PubMed ID: 7722448)
1. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease. Chuenkova M; Pereira ME J Exp Med; 1995 May; 181(5):1693-703. PubMed ID: 7722448 [TBL] [Abstract][Full Text] [Related]
2. Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase. Pereira ME; Zhang K; Gong Y; Herrera EM; Ming M Infect Immun; 1996 Sep; 64(9):3884-92. PubMed ID: 8751943 [TBL] [Abstract][Full Text] [Related]
3. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection. Tonelli RR; Torrecilhas AC; Jacysyn JF; Juliano MA; Colli W; Alves MJ Parasitology; 2011 Apr; 138(4):481-92. PubMed ID: 21040619 [TBL] [Abstract][Full Text] [Related]
4. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents. Tribulatti MV; Mucci J; Van Rooijen N; Leguizamón MS; Campetella O Infect Immun; 2005 Jan; 73(1):201-7. PubMed ID: 15618155 [TBL] [Abstract][Full Text] [Related]
5. The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies. Freire-de-Lima L; Fonseca LM; Oeltmann T; Mendonça-Previato L; Previato JO Glycobiology; 2015 Nov; 25(11):1142-9. PubMed ID: 26224786 [TBL] [Abstract][Full Text] [Related]
6. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate. Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic Applicability of Neutralizing Antibodies to Trypanosoma cruzi Trans-sialidase. Leguizamón MS Methods Mol Biol; 2019; 1955():239-246. PubMed ID: 30868532 [TBL] [Abstract][Full Text] [Related]
8. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice. Costa F; Franchin G; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM Vaccine; 1998 May; 16(8):768-74. PubMed ID: 9627933 [TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure/function studies towards the rational design of inhibitors. Buschiazzo A; Muiá R; Larrieux N; Pitcovsky T; Mucci J; Campetella O PLoS Pathog; 2012 Jan; 8(1):e1002474. PubMed ID: 22241998 [TBL] [Abstract][Full Text] [Related]
10. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections. Risso MG; Pitcovsky TA; Caccuri RL; Campetella O; Leguizamón MS Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease. Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671 [TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes. Duthie MS; Cetron MS; Van Voorhis WC; Kahn SJ Acta Trop; 2005 Mar; 93(3):317-29. PubMed ID: 15725381 [TBL] [Abstract][Full Text] [Related]
13. Identification of Trypanosoma cruzi trans-sialidase family members as targets of protective CD8+ TC1 responses. Wizel B; Nunes M; Tarleton RL J Immunol; 1997 Dec; 159(12):6120-30. PubMed ID: 9550413 [TBL] [Abstract][Full Text] [Related]
14. Enzyme-linked immunoassay using recombinant trans-sialidase of Trypanosoma cruzi can be employed for monitoring of patients with Chagas' disease after drug treatment. Pereira-Chioccola VL; Fragata-Filho AA; Levy AM; Rodrigues MM; Schenkman S Clin Diagn Lab Immunol; 2003 Sep; 10(5):826-30. PubMed ID: 12965912 [TBL] [Abstract][Full Text] [Related]
15. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080 [TBL] [Abstract][Full Text] [Related]
16. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections. Leguizamón MS; Campetella O; Russomando G; Almiron M; Guillen I; Ganzález Cappa SM; Frasch AC J Infect Dis; 1994 Dec; 170(6):1570-4. PubMed ID: 7995998 [TBL] [Abstract][Full Text] [Related]
17. Trans-sialidase, SAPA amino acid repeats and the relationship between Trypanosoma cruzi and the mammalian host. Frasch AC Parasitology; 1994; 108 Suppl():S37-44. PubMed ID: 8084653 [TBL] [Abstract][Full Text] [Related]
18. Virulence in Trypanosoma cruzi infection correlates with the expression of a distinct family of sialidase superfamily genes. Weston D; Patel B; Van Voorhis WC Mol Biochem Parasitol; 1999 Jan; 98(1):105-16. PubMed ID: 10029313 [TBL] [Abstract][Full Text] [Related]
19. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex. Mucci J; Hidalgo A; Mocetti E; Argibay PF; Leguizamon MS; Campetella O Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3896-901. PubMed ID: 11891302 [TBL] [Abstract][Full Text] [Related]
20. Sera from chronic Chagasic patients and rodents infected with Trypanosoma cruzi inhibit trans-sialidase by recognizing its amino-terminal and catalytic domain. Pereira-Chioccola VL; Schenkman S; Kloetzel JK Infect Immun; 1994 Jul; 62(7):2973-8. PubMed ID: 8005683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]